Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J ends Palomar deal

This article was originally published in The Gray Sheet

Executive Summary

Palomar says it will move forward with commercialization of its home-use, light-based technology for treatment of cellulite, skin aging and acne after Johnson & Johnson backed out of an agreement to market the product, citing economic conditions. The Burlington, Mass.-based firm received 510(k) clearance for the device for treatment of periorbital wrinkles in June (1"The Gray Sheet" June 15, 2009). Citing a multi-billion dollar market opportunity, Palomar CEO Joseph Caruso said the firm plans to launch the device for multiple applications in the second half of 2010. Near-term marketing efforts will focus on "certain specialty channels," Caruso said

You may also be interested in...

Palomar’s home-use laser for wrinkle removal

Palomar Medical Technologies gains 510(k) clearance June 5 for an over-the-counter, home-use laser for treatment of periorbital wrinkles - the first clearance of its kind, according to the company. The product will be marketed directly to consumers without a prescription by Johnson & Johnson under an existing agreement (1"The Gray Sheet" Sept. 13, 2004, p. 25). The device will enable laser wrinkle reduction "for a fraction of the cost" of similar treatments in the professional setting, according to Palomar

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts